Advarra

Advancing clinical research by enabling the research ecosystem to develop life-changing therapies.

Reviews | Consulting | Technology | Professional Services

[Advarra @advarra]

We're dedicated to serving the clinical research community at Advarra, and that means staying on top of the latest trends. Our new eBook, "2023 Trends Impacting Clinical Research," can help you stay informed and adapt to the changes.

#ClinicalResearch https://t.co/FVbFDsLUdf

[Advarra @advarra]

An investigator-initiated trial (IIT) occurs when an investigator creates the idea for a study, develops the protocol, and serves as the sponsor and investigator for the trial.

Download our latest eBook: https://t.co/a43F3P46X5

[Advarra @advarra]

Ethical oversight committees continue to innovate to keep pace with the rapid changes and evolution of research conduct.

https://t.co/zzcx2rVW1B

[Advarra @advarra]

Attending Cell & Gene Meeting on the Mesa? Let's chat! Advarra representatives will be onsite to learn about your challenges - and successes - in the cell and gene research space. We look forward to seeing you!

[Advarra @advarra]

Understanding the factors that influence the decision to participate in a study helps research professionals diagnose enrollment problems. https://t.co/jYaLS1NTjQ

[Advarra @advarra]

Research into participant experiences has consistently shown their desire to learn the results of research to which they’ve contributed. https://t.co/cRaZMHMnDL

[Advarra @advarra]

Curious about how #AI is used in clinical research? Want to learn more about discriminatory AI? Check out this podcast where IRB Chairperson Luke Gelinas and AI Ethics Advisor @ReidBlackman discuss #AIethics & the implications for #clinicalresearch. https://t.co/eVzQuL2zKK

[Advarra @advarra]

Advarra is proud to sponsor @nwabr's hybrid IRB conference "Back to Basics." Our own Julie Ozier will be opening the conference. We hope to see you there! Register today: https://t.co/3aR6TJO4E4

[Advarra @advarra]

Join Luke Gelinas and Reid Blackman Ph.D. on our latest podcast as they discuss artificial intelligence in clinical research. From discriminatory AI to the IRB review process, Luke and Reid dive into the exciting world of #AIEthics. https://t.co/pdRbZrJLTJ

[Advarra @advarra]

Regulatory agency guidance in the U.S. and EU strongly recommends keeping DSMBs completely independent from parties sponsoring, organizing, or conducting the clinical trial. Get the truth on what a DSMB does and how to set one up in this free white paper. https://t.co/kj6EwjzAGd

[Advarra @advarra]

Institutional sites are critical to successful clinical research and the advancement of healthcare. That’s why at Advarra, everything we do is driven by site centricity. In this blog, learn how Advarra plays a role in the movement toward site centricity. https://t.co/BuMUCADpL7

[Advarra @advarra]

In this podcast episode, Advarra’s Robann Cunningham and the Patient Empowerment Network’s Robin Barnes discusses patient empowerment and advocacy. Listen here: https://t.co/p1T3cWzvn7

[Advarra @advarra]

Establishing a compliant pharmacovigilance (PV) function from scratch is often an overwhelming exercise. Our blog outlines four critical questions to ask when supporting emerging biotech organizations as they establish a successful PV organization. https://t.co/b8bxE19Inj

[Advarra @advarra]

Join us for a two-part webinar series where in Part One, Advarra experts JV Rao and Wendy Tate examine the current state of #siteidentification and identify areas of risk mitigation and optimization opportunities. Register now: https://t.co/K0m0HhxEim

[Advarra @advarra]

In this blog, learn how we introduced the capability to store and manage additional key study documents; subject binders and standard operating procedures (SOPs). https://t.co/mA8lq0bccN #AdvarraeReg

[Advarra @advarra]

Are you attending #DIA2022? Advarra’s Sharon Ayd will present on the differences in CMC regulatory requirements globally and its impact on access to medicines: https://t.co/mpaMBPQSk3 #DIA2022

[Advarra @advarra]

Are you attending #DIA2022? Advarra’s Sharon Ayd will present on the differences in CMC regulatory requirements globally and its impact on access to medicines: https://t.co/mpaMBQ8tID #DIA2022

[Advarra @advarra]

Advarra is attending CAR & T Cell Therapie’s conference on “Improving the Safety and Efficacy of Your Novel CAR Modalities Through Translational Science and Cutting Edge Clinical Data”. We are excited to discuss innovations in CAR-T Therapy: https://t.co/ypp4DozH1x

[Advarra @advarra]

#Clinicalresearch professionals routinely interact with IRB and IBC, but what other committees are reviewing research? @JR_KinetiqIdeas will delve into the role and function of DMCs and EACs in @ACRPDC's upcoming #webinar! Register now: https://t.co/61szTKEUBT

[Advarra @advarra]

We are excited to partner with Blackstone and Canada Pension Plan Investment Board as we work to make clinical research safer, smarter and faster. https://t.co/S2I1Ss5sDc